Application Note Pall SoloHill Microcarriers in the PadReactor™ Single-Use Bioreactor

advertisement
Application Note
USD 2975(2)
Pall SoloHill® Microcarriers in the PadReactor™
Single-Use Bioreactor
Table of Contents
1. Introduction ..................................................................................................................................................3
2. Materials and Methods................................................................................................................................4
2.2 Cells and Media ......................................................................................................................................4
2.3 Microcarrier Mixing ..................................................................................................................................4
2.4 Bioreactor Culture Conditions ..................................................................................................................4
2.5 Serial Passage Conditions ......................................................................................................................5
2.6 Bioreactor and Spinner Culture Sampling ................................................................................................5
2.7 Cell Enumeration......................................................................................................................................5
3. Results .........................................................................................................................................................6
3.1 Microcarrier Mixing ..................................................................................................................................6
3.2 Bioreactor Culture....................................................................................................................................6
3.3 Serial Passage ........................................................................................................................................7
4. Conclusions..................................................................................................................................................7
2
1.
Introduction
Microcarriers provide a large surface area for growth of anchorage-dependent cell types and make
possible the use of bioreactors for generation of large numbers of adherent cells under current good
manufacturing processes (cGMP). Presently, microcarriers are used in a wide array of applications with a
diverse range of cell types for the production of biologicals and vaccines, and for the generation of stem
cells for cell therapies and regenerative medicine. Within each application, there exists the challenge
of providing environmental conditions that promote optimal cell growth and quality end products. To
meet this challenge, Pall offers an assortment of microcarrier types with varying densities and unique
combinations of surface chemistries and coatings. Microcarriers for serum-containing or animal
protein-free (APF) applications are available. This portfolio provides users with options to select
a microcarrier that excels in their bioreactor platform.
The recent emergence of disposable bioreactor technology, such as the PadReactor bioreactor (Figure 1),
has provided a useful platform for the manufacture of biologics. These systems expedite cGMP clinical
and commercial production by improving process reliability and reducing costs with greater flexibility. The
bioreactor vessel, which offers comparable functionality to classic stirred tank bioreactors, is a single use
cube-shaped bag integrating an internal paddle mixer with a sparger system. The PadReactor bioreactor
offers an open architecture controller platform which gives the end user the opportunity to use the
companion control system or to choose a preferred controller.
Figure 1
PadReactor Bioreactor
Pall SoloHill Collagen microcarriers in PadReactor bioreactor
The purpose of this study was to demonstrate the compatibility and performance of Pall SoloHill Collagen
microcarriers in single-use PadReactor bioreactor. The solid polystyrene core of the collagen-coated
microcarriers prevents absorption of serum or cell products into the core of the microcarrier, and the
1.03 specific gravity and 125-212 micron diameter allow them to be maintained in suspension with
a gentle low stirring speed. They can be sterilized by autoclaving at temperatures up to 130 °C, or via
gamma irradiation doses of 25 to 40 kGy with no deleterious effects on function. These features combine
to provide an excellent substrate for cell growth (Figure 2).
www.pall.com/biopharm
3
Figure 2
Vero Cells
Day 7 Vero cells on Collagen microcarriers in the PadReactor bioreactor
2.
Materials and Methods
2.1
Microcarriers, Bioreactor and Spinners
Collagen microcarriers (Pall # C102-1521) were used at a final concentration of 30 g/L.
A 25 L single-use PadReactor bioreactor (Catalog # 704782) disposable bioreactor bag retrofitted with a perfusion filter was employed using the conditions described in this report. Corning◆
brand 250 mL Glass Spinner Flasks (Catalog # 4500-250) were used for serial passaging.
4
2.2
Cells and Media
Vero Monkey Kidney cells (ATCC CCL-81) were used at Passage 131. Complete media for cell
growth was Dulbecco’s Modified Eagle Medium (DMEM; HyClone◆ SH30585.02), 1% Non
Essential Amino Acids (Hyclone SH30238.01), 2 mM L-Glutamine (Hyclone SH30034.01) and
1% antibiotic/antimycotic (Mediatech 30-004-C1) supplemented with 5% fetal bovine serum
(FBS; HyClone SH30071.03) unless otherwise specified.
2.3
Microcarrier Mixing
To evaluate the mixing capabilities of the PadReactor bioreactor system containing Collagen
microcarriers with a 1.03 density, the microcarrier distribution was mapped at various impeller
speeds by collecting samples from multiple positions and depths in the bioreactor bag. Samples
from the top, middle and bottom of the bag at all four corners of the bioreactor were retrieved
and dried overnight in an oven and the resultant microcarrier weight for each sample was
measured on an analytical balance. To determine percent mixing, the empirically-determined
mass of microcarriers in each sample was compared to the predicted microcarrier concentration
if 100% mixing occurred. Thus, the equation used to determine percent mixing was: % mixing =
(measured microcarrier weight/predicted weight at 100% mixing) x 100.
2.4
Bioreactor Culture Conditions
Temperature was maintained at 37 °C, agitation rate was continuous (35-45 rpm), dissolved
oxygen (DO) concentration was maintained at 30-40% of air saturation at sea level, and
pH controlled at 7.0-7.4. During the culture period DO was controlled by oxygen overlay
(100 mL/min) as well as through a 2 mm macrosparger that was fixed on the mixing paddle
(100-200 mL/min). The culture pH was controlled by air overlay and addition of 2.5 N NaOH
as needed (Figure 3). Media perfusion began two days after culture initiation and continued
through Day 6 at ~150% volume changed per day for a total utilization of 92 L as demanded
by an escalating high density Vero culture.
Figure 3
Dissolved Oxygen
8.0
100
7.5
7.0
6.5
60
6.0
40
pH
DO (%)
80
5.5
5.0
20
4.5
0
0
24
48
72
96
120
144
168
4.0
Time (hours)
Regulation of dissolved oxygen (blue), and pH (red) during cultivation
On the day of culture initiation, 450 grams of the collagen-coated microcarriers (equivalent to
162,000 cm2) were pre-autoclaved in 900 mL of deionized water and added to the disposable
bioreactor bag containing 12.5 L of complete medium without FBS. The bioreactor was seeded
at 40 RPM with 225 mL of a single-cell suspension when the DO content of the medium was
80% of air saturation and pH was 7.45. This resulted in a final cell concentration of 0.2 x 106
cells which is equivalent to a seeding density of 1.7 x 104 cells/cm2 or approximately 14 to 16
cells per bead.
Once cells attached to more than 90% of the collagen microcarriers, FBS and medium were
sequentially added at volumes which resulted in a final concentration of 5% FBS in the 15 L
culture. Post cell seeding, the DO concentration and pH both drifted down within the bioreactor
operating range (DO concentration; 30-40% of air saturation, pH 7.0-7.4). These conditions were
maintained for the remainder of the bioreactor run.
2.5
Serial Passage Conditions
Cells harvested from the PadReactor bioreactor were used to seed a spinner containing fresh
collagen-coated microcarriers. After seeding, the culture was maintained at 37 °C, 5% CO2, with
a continuous agitation rate of 35 rpm in a water-jacketed incubator. The spinner was prepared
and autoclaved according to the protocol found in the Pall SoloHill microcarrier protocols(1),
with 6 g of microcarriers suspended in 25 to 30 mL of deionized (DI) water. After autoclaving,
the DI water was carefully decanted through the side arm of the spinner flask without loss of
microcarriers. Afterwards, 150 mL of the DMEM medium without FBS was added to sterile
flasks and spinners were stirred at a constant rate of 40 rpm.
www.pall.com/biopharm
5
The spinner was seeded with 3 mL single cell suspension in 5% FBS-containing complete
medium for a final cell concentration of 0.2 x106 cells/mL (1.7x104 cells/cm2; approximately
16 cells per microcarrier). Once cells attached to more than 90% of the microcarriers, FBS and
medium were sequentially added at volumes which resulted in a final concentration of 5% FBS
in the 15 L culture.
3.
2.6
Bioreactor and Spinner Culture Sampling
Bioreactor culture samples were retrieved daily at 40-50 rpm to evaluate cell growth on
microcarriers. Prior to sampling, the sample line was purged with 60 mL of culture using a
60 mL syringe attached to the front port (port 11). A 20 mL sample was then immediately
collected in a 20 mL syringe for counts. Spinner culture samples were also retrieved daily at
40-50 rpm to evaluate cell growth on microcarriers. Three aliquots (1 mL each) of culture were
retrieved with a Finnpipette◆ (Fisher T21346) at the 150 mL mark on the spinner and aliquots were
pooled and images of cell-laden microcarriers were captured via phase contrast microscopy.
2.7
Cell Enumeration
Immobilized cell density was estimated by cell lysis with an aqueous Triton◆ X-100 (0.5%) and
citric acid (0.1 M) solution; subsequent counting of released intact cell nuclei was performed
with a Cellometer◆ Auto T4 cell counter (Nexcelom Bioscience.)
Results
3.1
Microcarrier Mixing
Collagen microcarriers with a relative density of 1.03 exhibited an optimal distribution between
30 and 50 rpm, as seen in Figure 4. At these speeds the PadReactor bioreactor’s mixing
performance was very high and therefore these conditions were chosen for subsequent
cell growth studies.
Figure 4
Mixing Profile
100
% Mixing
80
60
40
20
0
Location in Bioreactor Bag
0.1
9
18
bottom
mid
top
Mixing profile of the Pall SoloHill 1.03 density Collagen microcarriers in the PadReactor bioreactor. Blue line represents
samples take at 30 rpm and red line 50 rpm.
3.2
6
Bioreactor Culture
Microscopic examination of a representative sample retrieved from the bioreactor one hour after
culture initiation revealed that cells had attached and begun to spread onto more than 90% of
the microcarriers. At day 1, it was apparent that cells had begun to grow on about 90% of the
microcarriers (Figure 5).
Figure 5
Bioreactor Culture
Within one hour post seeding, Vero cells started attaching to Collagen microcarriers.
By 72 hours most microcarriers were confluent (Figure 6) and at day 7, Vero cells had grown
5.9 generations, reaching a cell concentration of 11.2 x 106 cells/mL (Figures 7, 8). Glucose
concentration was maintained with perfusion through day 6 (Figure 8). The decline in glucose
levels measured on day 7 was due to terminating medium perfusion on day 6.
Figure 6
Bioreactor Culture
At least 90% Collagen microcarriers reached confluency by 72 hours
Figure 7
Bioreactor Culture
High-density culture on day 7
www.pall.com/biopharm
7
12
3500
10
3000
8
2500
2000
6
1500
4
Glucose mg/L
Cells x 106/mL
Figure 8
Growth Curve
1000
2
500
0
0
24
48
72
96
120 144 168
0
Time (hours)
High density growth curve (red) of Vero cells on Collagen microcarriers in a 25 L PadReactor bioreactor. Glucose concentration (blue) was maintained with media perfusion through Day 6.
3.3
Serial Passage
To demonstrate the feasibility of serial passaging high density cultures, Vero cells harvested from
an aliquot of the entire bioreactor culture were used to seed a 250 mL spinner containing fresh
collagen-coated microcarriers. Viability of this cell suspension was 98% and cells efficiently
attached and spread on microcarriers when seeded into the spinner. A conservative estimate
using cell numbers obtained from the bioreactor sample indicates that this 15 L culture could be
used to seed at least one 300 L bioreactor containing an equivalent microcarrier concentration
of 30 g/L providing a split ratio of 1:20. This estimate assumes an 80% cell recovery obtained
from the entire bioreactor contents during harvesting. Monitoring spinner cultures seeded with
bioreactor-derived cells revealed that the cells attached and spread on over 90% of the collagencoated microcarriers one day after seeding and by 72 hours had grown to near confluence
(Figure 9).
Figure 9
Cell Images
A
B
Images of Vero cells grown on Collagen microcarriers for 1 (A) and 3 (B) days. Cells were harvested from the
PadReactor bioreactor and passaged to spinners.
8
4.
Conclusions
The results reported here demonstrate compatibility and performance of the Pall SoloHill Collagen
microcarriers in the PadReactor single-use bioreactor. In addition, the data show that cells derived from
high-density culture can be serially passaged to fresh microcarriers for cell expansion. The focus of our
process development studies with Vero cells on collagen-coated microcarriers was to identify the best
dynamic conditions for high-density cultures. This was accomplished in feasibility studies performed
in small-scale spinners before transition into the bioreactor format (data not shown). These previouslyidentified culture conditions were scaled up to the bioreactor, and growth of Vero cells on the microcarriers
in the disposable bioreactor was exceptional (Figures 7, 8 & 9).
These data show that Collagen microcarriers employed in the PadReactor bioreactor represent an
attractive platform for generating large numbers of cells in a small footprint. The resultant cells could
be harvested and used for subsequent passage into a larger independent reactor containing microcarriers
or, with proper developmental efforts, for cell expansion in a single reactor through addition of fresh
microcarriers and media. Additionally, the efficient attachment obtained when reduced FBS is present in
the media and the subsequent rapid growth profile observed upon subsequent culture with FBS indicate
that cells could be infected for virus production after as little as three days of culture.
The results obtained here lay the foundation for subsequent studies exploring virus production in
this platform in both serum-containing and animal component-free systems. Additionally, these data
demonstrate that the single-use PadReactor bioreactor, coupled with Collagen microcarriers, provides
an attractive platform for expansion of cells required for seeding large bioreactors used for vaccine
production.
Visit us on the Web at www.pall.com/biopharm
E-mail us at microcarriers@pall.com
Customer Ordering
Pall Life Sciences
4370 Varsity Drive, Suite B
Ann Arbor, MI 48108
microcarriers@pall.com
734-973-2956 phone
Corporate Headquarters
Port Washington, NY, USA
+1.800.717.7255 toll free (USA)
+1.516.484.5400 phone
biopharm@pall.com e-mail
European Headquarters
Fribourg, Switzerland
+41 (0)26 350 53 00 phone
LifeSciences.EU@pall.com e-mail
Asia-Pacific Headquarters
Singapore
+65 6389 6500 phone
sgcustomerservice@pall.com e-mail
International Offices
Pall Corporation has offices and plants throughout the world in locations such as: Argentina,
Australia, Austria, Belgium, Brazil, Canada, China, France, Germany, India, Indonesia, Ireland,
Italy, Japan, Korea, Malaysia, Mexico, the Netherlands, New Zealand, Norway, Poland, Puerto
Rico, Russia, ingapore, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, the United
Kingdom, the United States, and Venezuela. Distributors in all major industrial areas of the
world. To locate the Pall office or distributor nearest you, visit www.pall.com/contact
The information provided in this literature was reviewed for accuracy at the time of publication.
Product data may be subject to change without notice. For current information consult your
local Pall distributor or contact Pall directly.
© 2015, Pall Corporation. Pall,
, Hillex and PadReactor are trademarks of Pall
Corporation. ® indicates a trademark registered in the USA and TM indicates a common
law trademark. Filtration.Separation.Solution. is a service mark of Pall Corporation.
◆Cellometer is a trademark of Nexcelom Bioscience; Corning is a trademark of Corning,
Inc.; Finnpipette is a registered trademark of Thermo Fisher Scientific; HyClone is a
trademark of GE Healthcare; Triton is a trademark of The Dow Chemical Company; ATCC
is a trademark of ATCC (American Type Culture Collection, Inc.) and HyClone is a
trademark of Hyclone Laboratories, Inc.
2/15, PDF, GN15.6125
USD2975(2)
Download